Connecticut Gov. Ned Lamont has introduced a draft bill to legalize adult-use cannabis in the state, according to The CT Mirror.
Lamont announced during his Jan. 6 State of the State address that legalization is a priority this year, and his administration is currently seeking feedback on the draft legislation, although it remains to be seen whether Lamont will incorporate the proposal into his state budget, which is due to lawmakers next month, The CT Mirror reported.
Lamont’s proposal would tax dry cannabis at $1.25 per gram, trimmed cannabis plants at $0.50 per gram and wet cannabis at $0.28 per gram, according to the news outlet, and would also levy a 6.35% sales tax on adult-use sales. A 3% surcharge would also be added, with part of these funds going to local municipalities.
The draft bill also includes expungement provisions, The CT Mirror reported, which would automatically clear convictions for the possession of less than 4 ounces of cannabis that occurred before Oct. 1, 2015, as well as allow those convicted after that date to petition the state for expungement.
The legislation also includes marketing limitations to ensure youth are not targeted in cannabis advertising, as well as increases the number of trained drug recognition experts in state and municipal police departments, according to The CT Mirror. The draft bill would also update Connecticut’s Clean Air Act to include cannabis and vaping within the state's existing restrictions on secondhand smoke, the news outlet reported.
Lamont outlined adult-use cannabis legalization as a priority in his 2020 State of the State address, as well, and worked alongside the chairmen of key legislative committees last year to draft a comprehensive legalization bill before much of the 2020 legislative session was derailed in the wake of the COVID-19 pandemic.
Noel | Adobe Stock
Virginia Senate Panel Advances Adult-Use Cannabis Legalization Bill
The Senate Rehabilitation and Social Services Subcommittee voted 4-3 to approve a legalization measure backed by Gov. Ralph Northam.
A Virginia Senate panel approved an adult-use cannabis legalization bill Jan. 20, advancing it to the next committee for consideration, according to a local WRIC report.
The Senate Rehabilitation and Social Services Subcommittee voted 4-3 to approve the legalization measure, which is sponsored by Sen. Adam Ebbin (D-Alexandria) and Senate President Pro Tempore Louise Lucas (D-Portsmouth), and backed by Gov. Ralph Northam.
The legislation, as proposed by Northam, would allow adults 21 and older to legally purchase cannabis starting in 2023, and would establish a regulatory framework overseen by the Virginia Alcoholic Beverage Control Authority and a seven-member Cannabis Control Advisory Board, WRIC reported.
At an initial hearing Jan. 19, the Senate Rehabilitation and Social Services Subcommittee recommended creating a new, independent agency to oversee an adult-use cannabis market in the state, according to the news outlet, and recommended delaying the proposed 2023 launch six months to a year to allow more time to establish regulatory oversight.
The bill now advances to the Senate Rehabilitation and Social Services Committee for consideration, WRIC reported.
Unifor and Aleafia Health Enter Exclusive Agreement to Support Medical Cannabis Coverage for Members
The companies will support union members, retirees and their eligible dependents who receive medical cannabis insurance coverage through Unifor’s collective bargaining agreements.
TORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Unifor and Aleafia Health Inc. have entered into an exclusive 10-year agreement to support union members, retirees and their eligible dependents who receive medical cannabis insurance coverage through Unifor’s collective bargaining agreements.
"Unifor members across the country deserve access to the benefits of medical cannabis coverage through their benefits. As a union, we will support our local bargaining committees to add this coverage where possible," said Jerry Dias, Unifor National President.
The agreement supports a historic breakthrough in access to legal cannabis in Canada.
Aleafia brings unique national scale, organization and expertise to provide union members, retirees and their eligible dependents with access to medical cannabis product insurance reimbursement and physician-led cannabinoid therapy.
“This agreement will provide thousands of union members and their families with improved and affordable access to medical cannabis care, and ultimately be one of the largest breakthroughs in patient access since the early days of legalization in Canada,” said Geoffrey Benic, Aleafia Health CEO. “Our dedicated team of medical professionals and program managers are excited to begin working directly with Unifor members and launching this program.”
Through its subsidiaries, Aleafia Health provides an enhanced level of service not available through any other Canadian cannabis company. Members will receive a customized wellness regime, including cannabis education, virtual physician consultation, medical authorization, when appropriate, product ordering and scheduled home delivery, all in one business day.
Physician Expertise: Aleafia Health is a pioneer in cannabinoid therapy in Canada, providing care to over 75,000 unique patients. This has also provided actionable data on best practices on dosing, modes of intake, strain selection and patient safety, resulting in peer reviewed research published in medical journals. Best in class electronic medical records systems also allow close collaboration between Canabo physicians and Unifor members’ family doctor.
Virtual Consultation: Canabo today serves patients in every province of Canada. Since the beginning of Covid-19, the company has transitioned to completing 100% of consultations online and over the phone, allowing patients to receive professional care from the safety and convenience of their homes.
Product Portfolio: Through its flagship medical cannabis brand Emblem, members will benefit from access to a diverse portfolio of high-quality cannabis formats, including oils, capsules, sprays, sublingual strips, vapes and exclusive dried flower cultivars. In addition, the company looks forward to releasing a new line of CBD wellness products, which includes formats not yet available in Canada.
Scheduled Same Day Delivery: Through its AssureHome Delivery platform, Unifor members can order and will receive their medical cannabis order that evening, with best in class delivery times.
As Canada’s largest private sector union, Unifor represents over 315,000 members across every sector of the Canadian economy. Aleafia Health, a global cannabis health and wellness company, has provided over 75,000 individual patients with cannabinoid therapy through its national network of clinics, along with access to high-quality, federally regulated medical cannabis products.
lunamarina/Adobe Stock
What to Expect from President Biden’s Cabinet on Cannabis
We’ve highlighted four names from the group President Biden has chosen to shape federal policy under his administration and analyzed what each of their selections might mean for cannabis.
We’ve highlighted four names from the group President Biden has chosen to shape federal policy under his administration and analyzed what each of their selections might mean for cannabis.
The new administration has been sworn in, the Senate gavel has been passed to the Democrats, and the country’s leadership is almost fully set. One major step remains: the Cabinet nomination and approval process.
As we saw from the previous administration, Cabinet members can have a massive impact on the direction of the country, especially as it relates to cannabis policy. With a thin Democratic majority in Congress and a longtime moderate in the White House, the battle for fair cannabis laws is far from over.
Advocates are now looking to Biden’s Cabinet for clues on how the incoming administration will handle cannabis laws. Like the president they’ll be working under, the group doesn’t have a strong positive or negative stance on the plant. But taking a closer look at the previous records of the cabinet members announced so far can provide clues as to what we can expect from the incoming executive branch on cannabis laws.
Attorney General: Merrick Garland
White House
Before 2021, Garland was best known for being President Obama’s nominee to replace Antonin Scalia on the Supreme Court of the United States in 2016. After his Senate hearing was blocked by Republicans, Garland became an early symbol of the kind of Trump-era partisanship that still divides the country today. It appears Garland will get the chance to serve at the highest level of the federal government, but in a different branch: Biden announced his nomination as AG in the first week of January.
Garland, a Democrat who served as Washington, D.C.’s chief judge from 2013 to 2020, hasn’t come out directly against or in favor of cannabis. The closest definitive opinion was in 2013, when the medical cannabis advocacy group Americans for Safe Access sued the Drug Enforcement Administration in an effort to remove cannabis from Schedule I. Garland was one of three D.C. federal judges who ruled in favor of the DEA, on the grounds that they were the ones who had done the research. “We’re not the scientists. They are,” he said during the case’s 2012 hearing.
During his 2016 Supreme Court nomination, some in the media believed his respect for science would lead him to be an ally to the industry—or at least not a direct foe like Trump’s first attorney general, Jeff Sessions. Given the major legislative achievements that have occurred since his SCOTUS nomination, it’s hard to see Garland presiding over a strongly anti-cannabis Department of Justice.
Health and Human Services Secretary: Xavier Becerra
Becerra succeeded now-Vice President Kamala Harris as California attorney general in 2017, after Harris was elected to the Senate. He offers a mixed bag on cannabis as the Golden State’s top cop: As recently as October 2020, his California Department of Justice was putting out press releases touting the destruction of over 1 million marijuana plants and talking about the dangers of illegal grow operations. His office frequently mentions the public safety and environmental threats posed by these underground businesses, often sharing statistics about the number of people they’ve arrested in the state each year.
On the other hand, Becerra has been a staunch defender of California’s right to regulate cannabis its own way. In January 2018, when Attorney General Jeff Sessions rescinded the Cole Memo that instructed the federal government to take a “hands-off” approach on regulating state cannabis markets, Becerra released a statement proclaiming, “In California we decided it was best to regulate, not criminalize, cannabis. ... We intend to vigorously enforce our state’s laws and protect our state’s interests.”
In 2017, Becerra also admitted to having personal experience with marijuana: “Yes, at a younger time, I tried it, yes. Meaning, meaning much younger,” he said. Aside from cannabis, Becerra has been at the forefront of California’s feud with former president Trump: His office filed over 100 lawsuits against the administration preceding the one he’ll work in.
Secretary of Commerce: Gina Raimondo
As the first female governor of Rhode Island, Raimondo led the push for legalization in the smallest state. Her January 2020 proposal went further than most legal-use states, calling for Rhode Island to establish government-run cannabis retailers similar to how alcohol is sold in some states. It was the second time she attempted to legalize in the state—the initial effort in 2019 wasn’t accepted by lawmakers.
Raimondo would take the office with her work cut out for her, as the country faces its worst economic downturn since the Great Depression and ongoing closures related to COVID-19. Asked about Rhode Island’s push to legalize in a December 2020 interview, she said: “My view: it is only a matter of time. I think we should do it.” It’s tough to imagine Raimondo not bringing her pro-cannabis attitude into a federal government that will start 2021 with a soaring deficit and millions of people in need of economic aid.
Assistant Secretary of Health: Dr. Rachel Levine
Dr. Levine has been Pennsylvania’s Secretary of Health since 2017. In 2020, she was praised in the media for her handling of the state’s coronavirus crisis—the Pittsburgh Post-Gazette called her the “calm in the eye of the COVID-19 storm.” Dr. Levine has also been a leader in the growth of Pennsylvania’s medical marijuana program over the last few years. In 2019, she expanded the list of qualifying conditions to include anxiety and Tourette’s syndrome. When the pandemic began in March, she loosened restrictions on medical marijuana caregivers to ensure all patients could still access their medicine despite statewide stay-at-home orders.
In a statement congratulating Dr. Levine on her nomination to serve as Assistant Secretary, Pennsylvania Gov. Tom Wolf called her “instrumental in establishing the state’s medical marijuana program.” Aside from her work in medical cannabis, Dr. Levine is noteworthy for being the first openly transgender person to be nominated for a cabinet position. If approved, she would be the highest-ranking transgender person to ever serve in federal government.
What comes next?
All of these Cabinet nominees must still be confirmed by the Senate, which is split 50-50 between the parties. Democrats have the tie breaking vote now that Vice President Harris has been sworn in and will preside over the Senate, but the partisanship and divisiveness of the Trump era will hang over the nomination process, which is expected to continue through the month.
Although these men and women will have a significant impact on cannabis policy in 2021 and beyond, like the president they’ll be working for, they’ve shown a long-running deference to the will of constituents and Congress. They may not be zealous advocates of the fight to legalize, but none has signaled willingness to block state-level cannabis measures or expand federal enforcement of outdated prohibition laws.
@Keene.Media
Harvest at The Grove: How Fohse LED Fixtures Increased Yields and Drove Higher ROI
The numbers from a recent, late fall harvest tell an impressive tale.
When Mike Howard, director of cultivation at The Grove, first caught word of the record-breaking cannabis yields being harvested regularly by fellow grow teams around the country (Lume Cannabis in Michigan and Green Life Productions in Nevada)he knew the game was changing. Once Howard dug deeper into the news, he discovered a common catalyst behind the success of his peers: Both facilities were actively growing under the A3i LED grow light from Fohse.
After hearing firsthand from the grow teams in Michigan and Nevada how they had increased yields over HPS by 31% and 100% respectively, Howard knew he had to get Fohse lighting into The Grove—and fast!
The Grove, a vertically integrated cannabis business with dispensary, cultivation, distribution and production licenses, has been producing, sourcing and selling high quality edibles, cartridges and recreational cannabis products since 2015. Their 26,600-square-foot growing and production facility is state-of-the-art and eco-friendly. They strive to recreate the conditions that cannabis would find in nature and use only all-natural growing media and inputs as well as biological measures to control any pests or diseases. It only makes sense then that they would seek out and select Fohse products—the best lighting fixtures in the business—to match The Grove’s exacting standards.
The dry Las Vegas air makes for a challenging indoor growing environment for cannabis. Fohse fixtures operate at much cooler temperatures than standard HPS fixtures.
At The Grove, this means that the humidifiers and cooling systems don’t have to work as hard, and that an equilibrium between temperature and humidity level can be more easily achieved and maintained. This has led to some of the record harvests being seen regularly at The Grove.
Looking at how Fohse’s A3i 1500-watt fixtures compare to standard 1000-watt DE HPS fixtures in an “apples to apples” comparison reveals just how in sync these intelligent fixtures are with cannabis. The numbers from a recent, late fall harvest tell an impressive tale:
A3i 1500W LED
1000W DE HPS
Total Fixtures
35
64
Total Plant Count
520
520
Grow Media
Coco pots
Coco pots
Grow Area
1056 sf
1056 sf
Flower Cycle
65 days
65 days
PPFD (early flower)
800-820
800-820
PPFD (late flower)
1250-1350
1000-1050
Wet weight
1,392 lbs. (631.4 kg)
716 lbs. (324.8 kg)
Dry Weight
223 lbs. (101.3 kg)
135 lbs. (61.2 k g)
Yield in oz./ Square Foot
3.4 oz (96 g)
2.05 oz (58 g)
Lbs. of Cannabis/Light Fixture*
6.37 lbs. (2.98 kg)
2.11 lbs. (.96 kg)
Total kWh
41,072
49,155
*Strawberry Cheesecake was the highest-yielding strain at 7.2 lbs/light, while Cookies was the lowest at 5.49 lbs/light
In the now-typical example above from the fall of 2020, the A3i system generated an average of 27% more light as compared to the HPS fixtures. This additional light led to an increase in dry yield harvest weights by a whopping 65%. All of this, while using 16% less energy than the HPS lighting it was compared to and in the same physical footprint of space with the same number of plants.
Remarkable results like those at The Grove are not a fluke or an accident and they are not restricted to Howard and his team alone. Growers all over are finding results like these to be the new norm, regardless of growing media and style of growing.
Lume Cannabis has been tracking results of their Fohse A3i fixtures for over 40 hydroponic growing cycles and across eight different strains of cannabis. Without fail, the team at Lume under Kevin Kuethe’s direction reports higher yields under the A3i than those grown under HPS. For example, with Fohse fixtures they have harvested 7,130 lbs. versus 5,241 lbs. with the same strains grown under HPS. THC levels under Fohse lights have been 3% higher too; 20% versus 17% on average. In other words, the cannabis that Lume grew under Fohse lighting netted more than $2.5 million more than the cannabis grown under HPS.
@Keene.Media
Steve Cantwell at Green Life Productions also reports unbelievable differences since switching over to Fohse’s A3i and F1V fixtures. Green Life Production’s typical harvests under their previous lighting system clocked in at 80-90 lbs. The average harvest now using Fohse fixtures is 160 to nearly 200 lbs. pulled from their 4x8, no-till, living organic soil beds.
Like Howard’s team at The Grove, Cantwell and his team have the enviable logistics problem of figuring out where to put all of the bounty from these sky-high yields. All three teams, The Grove (coco pots), Lume Cannabis (hydroponics) and Green Life Productions (live soil), are blowing harvest records out of the water time and time again across three drastically different cultivation styles. These highly regarded and experienced cannabis producers are showing that the rules have changed and that Fohse lighting fixtures enable previously unobtainable and unthinkable results.
Howard and the grow team at The Grove have achieved their amazing results by relying on the horticultural skills of their talented team, and also by utilizing two of Fohse’s premier products. They have predominantly been using the A3i model, Fohse’s workhorse grow light, to achieve their highest yields. The A3i is specifically designed to grow cannabis and that is exactly what it does. Its spectral distribution is custom-made to address the unique needs of cannabis. As evidenced in the remarkable yields outlined in the table above, the A3i’s output (of up to 4,970 µmol/s depending on configuration) can be adjusted to supply seasonably appropriate lighting depending on the growth phase of the crop. All of this while producing up to 156% more light per fixture and burning cooler (no hotter than dishwashing water) than traditional HPS grow lights. This means the A3i is safer to operate for both growers and their cannabis crops.
The A3i system is designed to handle the harsh extremes of a growing environment. The IP67-rated fixture will continue to operate at peak performance even with the moisture, dust, pests and biological debris, such as spores that are present in most indoor growing environments. Not many growers would expect their grow lights to still perform well after being submerged under several feet of water; the A3i can survive such a plunge and be relied on to deliver its photon payload as designed. Howard and his team at The Grove do not just rely on the A3i for their high yields. In their double-stack rooms they deploy Fohse’s lighter, more nimble F1V for its pound-for-pound power.
Just like the A3i, the F1V fixtures rely on industry-proven Samsung LEDs for their photon delivery. While almost the same dimensions as the A3i, at 38 lbs. (17.2 kg) per fixture they are almost half the weight of each A3i (70 lbs./31.75kg each). Like the A3i fixtures, their power supply rating is +100,000 hours. Depending on the needs of the grower and the ability of the existing systems, Fohse offers 420W, 600W, and 800W versions of the F1V. In his own F1V rooms, Howard has reported similarly positive results as in his A3i rooms: 60%+ yield increases, increased utility efficiencies, and better labor efficiency. The team now does not have to “chase canopy” by raising and lowering the lighting fixtures to achieve late-flower PPFD intensities like they did with the old LED lights that they were using in those double-tiered systems.
Fohse lighting products outperform their competition not only at The Grove, but anywhere they have been put to the test. So why hasn’t every cannabis grower switched over to Fohse?
Growers who have not yet seen the results firsthand still believe that LEDs cannot keep up with the high lighting demands of cannabis the way that HPS lighting traditionally has. The narrative had long been one of incremental change and an acceptance that two pounds of harvested yields per light fixture was the best one could expect. At the turn of the century, there was chatter that this didn’t have to be “good enough.”
@Keene.Media
By 2015, growers both professional and amateur alike had proven that three pounds per light was achievable based on advancements up to that point, but no one thought it would ever get better than that. Until Fohse set out to prove them all wrong, and then did. They showed that higher light output does not have to mean higher heat and that Diode technology had come a long way in just a few short years. Howard gives his take on this phenomenon:
“Everyone looks at LED lighting as still kind of a novelty; not something where it needs to be yet for cannabis growers. Having seen the evolution of LEDs that the Fohse team has created because of their cannabis mindset, it became obvious that we could focus on producing healthy plants.
A lot of other grow lighting companies are still looking at making and selling lights that can grow anything. Cannabis takes a lot of light and many companies and even growers don’t put enough light into commercial setups. Many cannabis growers never thought that LED technology was ever going to make it, but the power that comes out of Fohse fixtures is insane. Fohse lighting lets the grower focus on plant health and our yields show that. With Fohse LEDs overtaking HPS, you can really push the limits of your grow.”
As Howard said, Fohse fixtures are engineered with a “cannabis mindset.” HPS light output has plateaued because the added heat load is both detrimental to the cannabis crop and uneconomical to counterbalance. With Fohse fixtures growers can focus more on the nuances of a high-intensity light environment instead of combatting heat. Ever since that first time Mike Howard oversaw production in the initial grow room where Fohse products were installed at the Grove, he immediately saw the results. He is now vowing to keep replacing The Grove’s less efficient HPS fixtures and outdated LEDs with Fohse lighting as they continue expanding. Find out how switching to Fohse fixtures will increase your cannabis production and about all of Fohse’s record-busting lighting at Fohse.com.
Legislative Map
Cannabis Business Times’ interactive legislative map is another tool to help cultivators quickly navigate state cannabis laws and find news relevant to their markets. View More